Global Preventive Asthma Drugs Market 2015-2019
About asthma
According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The symptoms worsen due to the increased secretion of mucus, bronchoconstriction, and thickening of the walls of the airways, resulting in difficulty in expiration. According to the American Academy of Allergy, Asthma, and Immunology, asthma is classified into four types: exercise-induced, allergic, occupational, and childhood. Also, asthma can be classified into two categories: allergic and non-allergic, as per the classification of Asthma and Allergy Foundation of America. Asthma can be managed by preventive medications, which should be administered to the patient regularly to improve his quality of life by controlling the exacerbations.
Technavio's analysts forecast the global preventive asthma drugs market to grow at a CAGR of 5.20% over the period 2014-2019.
Download Sample copy of this Report
http://www.marketresearchreports.biz/sample/sample/404944
Covered in this report
This report covers the present scenario and the growth prospects of the global preventive asthma drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of the following classes of drugs used to treat asthma:
Immunosuppressants
Leukotriene antagonists
Mast cell stabilizers
Corticosteroids
Combination of LABA/ ICS
This report includes a discussion of the market in the following three regions:
Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil
EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India
Technavio's report, Global Preventive Asthma Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global preventive asthma drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
AstraZeneca
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Novartis
Other prominent vendors
Abbott
Amgen
AptarGroup
Biotest
Boehringer Ingelheim
Key market driver : High prevalence of asthma
Key market challenge : Unknown disease etiology
Key market trend : Growing popularity of combination therapies
To Get Sample Copy of Report visit @ http://www.marketresearchreports.biz/analysis-details/global-preventive-asthma-drugs-market-2015-2019
Table of Content :
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Product profiles
Accolate
Pulmicort
Symbicort
Xolair
Browse Press Releases by Prweb :
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact us:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz